Literature DB >> 22857825

Exclusive elemental diet impacts on the gastrointestinal microbiota and improves symptoms in patients with chronic pouchitis.

S D McLaughlin1, A Culkin, J Cole, S K Clark, P P Tekkis, P J Ciclitira, R J Nicholls, K Whelan.   

Abstract

BACKGROUND: Treatment resistant chronic pouchitis causes significant morbidity. Elemental diet is effective treatment for Crohn's disease. Since pouchitis shares some similarities to Crohn's disease we hypothesised that elemental diet may be an effective treatment.
METHOD: Seven pouchitis patients (with ulcerative colitis) were studied. All had active pouchitis with a pouch disease activity index (PDAI) ≥7. Exclusion criteria were recent NSAIDs, antibiotics or probiotics. Sufficient elemental diet to achieve energy requirements was provided. Flexible-pouchoscopy was performed, and the Cleveland Global Quality of Life score (CGQoL), Pouch Disease Activity Index (PDAI) and BMI were recorded at baseline and following 28 days of elemental diet. Faecal samples were also collected at these time points and analysed for major bacterial groups using culture independent fluorescence in situ hybridisation. Data were analysed using Wilcoxon's signed-rank test.
RESULTS: Following 28 days of exclusive elemental diet, median stool frequency decreased from 12 to 6 per day (p=0.028), median clinical PDAI decreased from 4 to 1 (p=0.039). There was no significant difference in quality of life scores or PDAI before and following treatment. There was a trend towards an increase in the concentration of Clostridium coccoides-Eubacterium rectale (median 7.9 to 8.5 log₁₀/g, p=0.08) following exclusive elemental diet.
CONCLUSION: Treatment with four weeks elemental diet appeared to improve the symptoms of chronic pouchitis in some patients but is not an effective strategy for inducing remission. Although a potential symptom modifier, elemental diet cannot be recommended for the routine treatment of active pouchitis.
Copyright © 2012 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22857825     DOI: 10.1016/j.crohns.2012.07.009

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   10.020


  8 in total

1.  Update on the pathogenesis and management of pouchitis.

Authors:  Saleem Chowdhry; Jeffry A Katz
Journal:  Curr Infect Dis Rep       Date:  2014-12       Impact factor: 3.725

Review 2.  Dietary management of adults with IBD - the emerging role of dietary therapy.

Authors:  Jessica A Fitzpatrick; Sarah L Melton; Chu Kion Yao; Peter R Gibson; Emma P Halmos
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-05-16       Impact factor: 73.082

Review 3.  Ileal Pouch-Anal Anastomosis and Pouchitis: The Role of the Microbiota in the Pathogenesis and Therapy.

Authors:  Roberto Gabbiadini; Arianna Dal Buono; Carmen Correale; Antonino Spinelli; Alessandro Repici; Alessandro Armuzzi; Giulia Roda
Journal:  Nutrients       Date:  2022-06-24       Impact factor: 6.706

4.  Elemental diets role in treatment of high ileostomy output and other gastrointestinal disorders.

Authors:  Kamran Rostami; David Al Dulaimi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2015

5.  Oligomeric Enteral Nutrition in Undernutrition, due to Oncology Treatment-Related Diarrhea. Systematic Review and Proposal of An Algorithm of Action.

Authors:  Alejandro Sanz-Paris; María Martinez-García; Javier Martinez-Trufero; Julio Lambea-Sorrosal; Fernando Calvo-Gracia; María Elena López-Alaminos
Journal:  Nutrients       Date:  2019-08-13       Impact factor: 5.717

Review 6.  The Microbiome as a Therapy in Pouchitis and Ulcerative Colitis.

Authors:  Jean-Frédéric LeBlanc; Jonathan P Segal; Lucia Maria de Campos Braz; Ailsa L Hart
Journal:  Nutrients       Date:  2021-05-23       Impact factor: 5.717

7.  Long-term use of probiotics Lactobacillus and Bifidobacterium has a prophylactic effect on the occurrence and severity of pouchitis: a randomized prospective study.

Authors:  Banasiewicz Tomasz; Stojcev Zoran; Walkowiak Jarosław; Marciniak Ryszard; Grochowalski Marcin; Burdyński Robert; Krokowicz Piotr; Krokowicz Lukasz; Paszkowski Jacek; Gronek Piotr; Pyda Przemysław; Drews Michał
Journal:  Biomed Res Int       Date:  2014-01-21       Impact factor: 3.411

Review 8.  Irritable bowel syndrome, inflammatory bowel disease and the microbiome.

Authors:  Giles Major; Robin Spiller
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-02       Impact factor: 3.243

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.